Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 3Phase 4 1Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 4Head and Neck Neoplasms 3Pain 2Depression 2Breast Neoplasms 2Stomatitis 1Pancreatic Neoplasms 1Pain, Postoperative 1Mucositis 1Lung Neoplasms 1Choledocholithiasis 1Choledochal Cyst 1Cholangitis 1Cancer Pain 1Anxiety Disorders 1Agnosia 1

Interventions

Psilocybin 5Psychotherapy 2Fluoxetine 2Cannabidiol 2nabiximols 1Yoga 1Therapeutics 1Sertraline 1Self-Management 1Selective Serotonin Reuptake Inhibitors 1Professional Autonomy 1Pharmaceutical Preparations 1Niacin 1Neoadjuvant Therapy 1N-Methyl-3,4-methylenedioxyamphetamine 1Minocycline 1Medical Marijuana 1Ketamine 1Injections 1Hormones 1Gemcitabine 1Exercise 1Dronabinol 1Donepezil 1Clomipramine 1Citalopram 1Cisplatin 1Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anxiety Disorders × Ketamine × Clear all
NCT01680172 2016-02-29

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

Mayo Clinic

Phase 2 Terminated
5 enrolled 6 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡